Consumer Protection
California Attorney General Sues JPMorgan Chase Over Debt Collection
- California Attorney General Kamala Harris has announced that she has filed suit against JPMorgan Chase alleging the company engaged in fraudulent debt-collection practices.
- The complaint alleges that the company engaged in widespread, illegal robo-signing, among other unlawful practices, to commit debt-collection abuses against approximately 100,000 California credit card borrowers over at least a 3-year period.
- The suit seeks a permanent injunction barring the unlawful practices as well as restitution for injured consumers.
Maryland Attorney General Urges Advertisers to Cease Advertising on Ask.fm
- Maryland Attorney General Doug Gansler is urging several major advertisers to pull support from the Latvia-based, ad-supported website Ask.fm.
- The site has become a forum for anonymous attacks on children and has allegedly been linked to multiple teen suicides.
- In a letter sent to advertisers, the AG says that the website “not only allows ‘anonymous publication of malicious personal attacks on teenagers and children as young as 8 years old,’ but also appears to collect personal information about children in ways that violate the federal Children’s Online Privacy Protection Act (COPPA).”
Data Privacy
California Attorney General Won’t Back Down in Delta Privacy Suit
- Last week, citing federal preemption of the issue, a California judge tossed the state’s first attempt to sue Delta Airlines over alleged violations of state’s new data privacy statute requiring app manufacturers to clearly post privacy policies.
- Attorneys caution that this setback will not deter California Attorney General Kamala Harris from aggressively enforcing the state’s privacy laws. She has been a national leader in the data privacy field, and she is expected to continue her efforts.
- Dickstein State AG Practice partner Divonne Smoyer was quoted in a Law360 article on the California suit, stating that “State Attorneys General across the U.S. have picked up the topic of data security as a major issue, and have been urged on by federal regulators like the Federal Trade Commission to start exercising their authority. While this may be a hiccup and may cause them to take a look at things a little more closely, it won’t be a game changer or a game stopper.” Smoyer further noted that “states that have issues with loss of private information or companies that maintain inadequate security practices can use UDAAP statutes that are not very specific to sweep that up.”
Pharmaceuticals
Forty-three Attorneys General Send Letter to FDA Urging New Prescription Warnings
- Forty-three State Attorneys General sent a letter to the U.S. Food and Drug Administration (FDA) urging the FDA to adopt new black box labels for opiate-based prescription medications warning of the risk of Neonatal Abstinence Syndrome (NAS) caused by maternal opiate use while pregnant.
- Symptoms of NAS include malfunctions of the autonomic nervous system, respiratory system, and gastrointestinal tract, and occur after the baby is born and goes through opiate withdrawal.
- The AGs urge the warning to read: WARNING: USE OF NARCOTIC ANALGESICS IN PREGNANT WOMEN MAY CAUSE NEONATAL ABSTINENCE SYNDROME.
Pharmaceuticals and False Claims Act
Ranbaxy Settles with 50 States and the U.S. FDA
- Ranbaxy has reached a $500 million settlement with all 50 states and the U.S. Food and Drug Administration (FDA) over allegations that the company sold subpar generic drugs.
- The company has not sold drugs produced at the relevant Indian factories since 2008.
- The company also pleaded guilty to three felony counts of violating the federal drug safety law and four for making false statements to the FDA.
- The whistleblower that initially brought suit under the federal False Claims Act will receive close to $49 million.
- The settlement is the largest in history against a generic drug maker.